Comparison between visual score and erythema index (DermaSpectrometer) in evaluation of allergic patch tests.

Area of Science:

• Dermatology
• Allergology
• Bioengineering

Background:

• Objective evaluation of patch test reactions is an ongoing area of bioengineering research.
• The erythema index, measured by the DermaSpectrometer, offers a potential objective method for assessing patch test responses.
• Allergic contact dermatitis diagnosis relies heavily on accurate patch test interpretation.

Purpose of the Study:

• To evaluate the clinical utility of the DermaSpectrometer for measuring erythema index in allergic patch tests.
• To compare DermaSpectrometer readings with traditional visual assessments of patch test reactions.
• To determine if the DermaSpectrometer provides more objective data than visual inspection in formaldehyde patch testing.

Main Methods:

• Twenty patients with known formaldehyde allergy underwent patch testing with varying formaldehyde concentrations.
• Erythema index was measured using the DermaSpectrometer 24 hours after patch test removal.
• Clinical readings of patch test sites were performed concurrently, and a control group was included.

Main Results:

• Significantly higher erythema indices were observed in visually positive patch tests compared to negative ones (P<0.05).
• The DermaSpectrometer could not reliably differentiate between various grades of visually positive reactions.
• Correlation between visual clinical readings and formaldehyde concentration (r=0.60) was stronger than DermaSpectrometer readings (r=0.35).

Conclusions:

• The DermaSpectrometer did not provide superior information compared to visual readings in formaldehyde patch testing.
• Visual assessment remains a valuable method for interpreting patch test reactions, even with the availability of objective tools.
• Further research may be needed to refine bioengineering tools for more accurate patch test evaluation.